Dosing has successfully commenced with healthy volunteers Primary endpoints for the Phase 1 trial include safety, tolerability, and pharmacokinetic (PK) profile of the combination Topline data are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback